0000950170-24-018724.txt : 20240222
0000950170-24-018724.hdr.sgml : 20240222
20240222160007
ACCESSION NUMBER: 0000950170-24-018724
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240220
FILED AS OF DATE: 20240222
DATE AS OF CHANGE: 20240222
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Levisetti Matteo
CENTRAL INDEX KEY: 0001962444
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38327
FILM NUMBER: 24664564
MAIL ADDRESS:
STREET 1: C/O CUE BIOPHARMA, INC.
STREET 2: 40 GUEST STREET
CITY: BOSTON
STATE: MA
ZIP: 02135
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Cue Biopharma, Inc.
CENTRAL INDEX KEY: 0001645460
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 473324577
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 40 GUEST STREET
CITY: BOSTON
STATE: MA
ZIP: 02135
BUSINESS PHONE: 617-949-2680
MAIL ADDRESS:
STREET 1: 40 GUEST STREET
CITY: BOSTON
STATE: MA
ZIP: 02135
FORMER COMPANY:
FORMER CONFORMED NAME: Imagen Biopharma, Inc.
DATE OF NAME CHANGE: 20150617
4
1
ownership.xml
4
X0508
4
2024-02-20
false
0001645460
Cue Biopharma, Inc.
CUE
0001962444
Levisetti Matteo
C/O CUE BIOPHARMA, INC.
40 GUEST STREET
BOSTON
MA
02135
false
true
false
false
Chief Medical Officer
false
Stock Option (right to buy)
3.36
2024-02-20
4
A
false
25000
0.0
A
2033-01-16
Common Stock
25000
25000
D
On January 17, 2023 the Reporting Person was granted an option with vesting subject to the satisfaction of performance-based vesting criteria. The performance-based vesting criteria was deemed satisfied or waived on February 20, 2024 and these shares underlying the option vested in full.
/s/ Matteo Levisetti by Colin Sandercock, attorney-in-fact
2024-02-22